{"id":15355,"date":"2021-01-08T11:43:03","date_gmt":"2021-01-08T10:43:03","guid":{"rendered":"https:\/\/www.izb-online.de\/morphosys-ernennt-sung-lee-zum-chief-financial-officer\/"},"modified":"2021-01-08T15:28:36","modified_gmt":"2021-01-08T14:28:36","slug":"morphosys-ernennt-sung-lee-zum-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/","title":{"rendered":"MorphoSys Appoints Sung Lee as Chief Financial Officer"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12 vc_col-xs-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

MorphoSys Appoints Sung Lee as Chief Financial Officer<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]MorphoSys AG, a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced on January 6, 2021 the appointment of Sung Lee as Chief Financial Officer, effective February 2, 2021. Mr. Lee succeeds Jens Holstein, who stepped down in December 2020, and will lead all corporate finance functions as a member of the Management Board of MorphoSys AG. He will be based in Planegg, Germany.[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]January 2021[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote gco-magazine–quote-vertical-center”][vc_column_inner][vc_column_text]<\/p>\n

\"Sung-Lee-Portrait\"
\n\u00a9 MorphoSys AG<\/span><\/div>\n
\n
\u201cMorphoSys is a prime example of an R&D-focused company that has successfully evolved into a commercial-stage company, and I am very excited to help shape its future growth.\u201d<\/h6>\n

Sung Lee, CFO MorphoSys AG<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy” css=”.vc_custom_1610104311277{margin-top: 21px !important;}”][vc_column_inner css=”.vc_custom_1606254211295{margin-top: 0px !important;}”][vc_column_text]\u201cI am delighted to welcome Sung to MorphoSys while the company executes on its first commercial launch and is establishing itself as an emerging leader in hematology-oncology and autoimmune diseases,\u201d said Marc Cluzel, M.D., Ph.D., Chairman of the MorphoSys Supervisory Board. \u201cSung will bring a wealth of experience to the Management Board based on his excellent track record in scaling organizations and leading finance and investor relations functions in the U.S. and Europe.\u201d<\/p>\n

Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, added: \u201cThroughout his career, Sung has demonstrated tremendous talent in driving financial performance and serving as a strategic thought partner. We are convinced that Sung’s transformative mindset will be instrumental in executing our ambitious growth strategy and the accelerated development of our pipeline for the benefit of patients.\u201d<\/p>\n

\u201cI am thrilled to join MorphoSys and become part of a team that has proven its ability to make a real difference for people suffering from cancer,\u201d said Sung Lee. \u201cMorphoSys is a prime example of an R&D-focused company that has successfully evolved into a commercial-stage company, and I am very excited to help shape its future growth.\u201d<\/p>\n

Sung Lee has more than 20 years of finance leadership experience in biopharmaceutical and technology businesses. Mr. Lee joins MorphoSys from Sangamo Therapeutics, Inc., where he served as Chief Financial Officer. Prior to that role, Mr. Lee spent nearly 14 years at Gilead Sciences where he most recently led the global Financial Planning & Analysis and Investor Relations functions.<\/p>\n

Mr. Lee started his career in the tax advisory business at PriceWaterhouseCoopers LLP. He received a Master of Business Taxation from the University of Southern California and a B.A. in Economics from the University of California, Irvine.<\/p>\n

www.morphosys.com<\/a>[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

MorphoSys AG, a commercial-stage biopharmaceutical company and a leader in antibody,<\/span> protein and peptide technologies, announced on January 6, 2021 the<\/span><\/span><\/p>\n","protected":false},"author":8,"featured_media":15353,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[712,1539,6402],"tags":[],"class_list":["post-15355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-branchen-news","category-izb-biotech-news","category-top-news"],"yoast_head":"\nMorphoSys Appoints Sung Lee as Chief Financial Officer - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MorphoSys Appoints Sung Lee as Chief Financial Officer\" \/>\n<meta property=\"og:description\" content=\"MorphoSys AG, a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced on January 6, 2021 the appointment of Sung Lee as Chief Financial Officer, effective February 2, 2021. Mr. Lee succeeds Jens Holstein, who stepped down in December 2020, and will lead all corporate finance functions as a member of the Management Board of MorphoSys AG. He will be based in Planegg, Germany.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-08T10:43:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-08T14:28:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"341\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"martin Reznicek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"martin Reznicek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"martin Reznicek\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/d8c3fdae36f92a8c67f39af096dd9437\"},\"headline\":\"MorphoSys Appoints Sung Lee as Chief Financial Officer\",\"datePublished\":\"2021-01-08T10:43:03+00:00\",\"dateModified\":\"2021-01-08T14:28:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/\"},\"wordCount\":539,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/sung-lee.jpg\",\"articleSection\":[\"Alumni News\",\"IZB Biotech News\",\"Top News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/\",\"name\":\"MorphoSys Appoints Sung Lee as Chief Financial Officer - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/sung-lee.jpg\",\"datePublished\":\"2021-01-08T10:43:03+00:00\",\"dateModified\":\"2021-01-08T14:28:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/sung-lee.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/sung-lee.jpg\",\"width\":400,\"height\":341},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/morphosys-appoints-sung-lee-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/top-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MorphoSys Appoints Sung Lee as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/d8c3fdae36f92a8c67f39af096dd9437\",\"name\":\"martin Reznicek\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MorphoSys Appoints Sung Lee as Chief Financial Officer - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"MorphoSys Appoints Sung Lee as Chief Financial Officer","og_description":"MorphoSys AG, a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced on January 6, 2021 the appointment of Sung Lee as Chief Financial Officer, effective February 2, 2021. Mr. Lee succeeds Jens Holstein, who stepped down in December 2020, and will lead all corporate finance functions as a member of the Management Board of MorphoSys AG. He will be based in Planegg, Germany.","og_url":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_published_time":"2021-01-08T10:43:03+00:00","article_modified_time":"2021-01-08T14:28:36+00:00","og_image":[{"width":400,"height":341,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg","type":"image\/jpeg"}],"author":"martin Reznicek","twitter_card":"summary_large_image","twitter_misc":{"Written by":"martin Reznicek","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/"},"author":{"name":"martin Reznicek","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/d8c3fdae36f92a8c67f39af096dd9437"},"headline":"MorphoSys Appoints Sung Lee as Chief Financial Officer","datePublished":"2021-01-08T10:43:03+00:00","dateModified":"2021-01-08T14:28:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/"},"wordCount":539,"commentCount":0,"publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg","articleSection":["Alumni News","IZB Biotech News","Top News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/","url":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/","name":"MorphoSys Appoints Sung Lee as Chief Financial Officer - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg","datePublished":"2021-01-08T10:43:03+00:00","dateModified":"2021-01-08T14:28:36+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2021\/01\/sung-lee.jpg","width":400,"height":341},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/morphosys-appoints-sung-lee-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"Top News","item":"https:\/\/www.izb-online.de\/en\/top-news\/"},{"@type":"ListItem","position":3,"name":"MorphoSys Appoints Sung Lee as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/d8c3fdae36f92a8c67f39af096dd9437","name":"martin Reznicek"}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/15355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/comments?post=15355"}],"version-history":[{"count":44,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/15355\/revisions"}],"predecessor-version":[{"id":15404,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/15355\/revisions\/15404"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/15353"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=15355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/categories?post=15355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/tags?post=15355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}